80 Followers on Owler

APR identifies, develops, manufactures and licenses healthcare products...

Read more

APR identifies, develops, manufactures and licenses healthcare products...

Read more
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$0

News

Nov 21, 2022
Life Care News
APR: APR Applied Pharma Research (a Subsidiary of Relief Therapeutics) is a Finalist in the 2022 Rare Disease International Film Festival
Mar 17, 2022
FirstWord Pharma
APR: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Final Data from Its Clinical Trial of Novel Nasal Spray, Sentinox, in SARS-CoV-2 Infected Patients
Mar 15, 2022
FirstWord Pharma
APR: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research Signs an Agreement To Acquire Rights to Commercialize a Novel Dosage Form for the Treatment of PKU
Mar 15, 2022
BioSpace
APR: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research Signs an Agreement To Acquire Rights to Commercialize a Novel Dosage Form for the Treatment of PKU
Jan 24, 2022
centralcharts
Press Release: APR : EQS-Adhoc: Relief Therapeutics' Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs
Oct 28, 2021
Pharmabiz
APR: Relief Therapeutics' subsidiary, APR announce positive interim data from clinical trial of novel nasal spray Sentinox in SARSCoV2 infected patients
Jun 29, 2021
BioSpace
APR: Relief and APR Applied Pharma Research Sign and Close Definitive Agreement for Relief to Acquire All Outstanding Shares of APR
May 12, 2021
FinanzNachrichten
APR Applied Pharma Research: Initiated clinical trial with novel nasal spray codenamed APR-AOS2020 in patients with mild COVID-19
May 10, 2021
Global Legal Chronicle
APR Applied Pharma Research: Relief Therapeutics' Acquisition of Applied Pharma Research S.A.
May 05, 2021
Seeking Alpha
APR Applied Pharma Research: Relief inks binding term sheet to acquire outstanding shares of APR Applied Pharma

APR News

APR Press Releases

APR Headquarters

Via Corti 5

Balerna, Ticino6828

41-91-6957020

Driving Directions »

APR Summary

ABOUT

Overview

APR identifies, develops, manufactures and licenses healthcare products. APR was founded in 1990. APR's headquarters is located in Balerna, Ticino, CH 6828. APR has an estimated 49 employees and an estimated annual revenue of 6.4M....

Website

apr.ch

Competitors

There are no competitors identified for APR

Acquisitions

There have been no acquisitions found related to APR

Funding

Funding data cannot be found related to APR

Investments

Recent investment data cannot be found related to APR

Frequently Asked Questions about APR

  1. When was APR founded?

    APR was founded in 1990
  2. Who is APR's CEO?

    APR's CEO is Paolo Galfetti
  3. How much revenue does APR generate?

    APR generates $6.4M in revenue
  4. How much funding does APR have?

    APR has historically raised $0 in funding
  1. Where is APR's headquarters?

    APR's headquarters is in Balerna Ticino, CH
  2. How many employees does APR have?

    APR has 49 employees
  3. What sector does APR operate in?

    APR is in Pharmaceuticals

Trending Companies